Loading...

Daily news and top headlines for life science research professionals

FREE Email Newsletter View Sample


4 funds that beat the market and keep costs low

By MARK JEWELL - AP Personal Finance Writer - Associated Press Thursday, August 23, 2024

See today's top life science stories and headlines - Sign up now!

newsvine diigo google
slashdot
Share
Loading...

An index mutual fund is a sensible option for building a diversified stock portfolio while keeping investment costs under control. The approach is simple: The fund holds the same stocks as the segment of the market it tracks. Expenses are low because there's no professional manager picking the investments.

But you also give up something with an index approach. You're guaranteeing that you'll never beat the market. In fact, you'll come up a bit short, because the modest fees that index funds charge are shaved off investment returns.

If that proposition isn't appealing, consider funds run by pros who try to outperform the market. With a little research, an investor can find managed funds charging fees that aren't far above those assessed by some higher-cost index funds. And several among that select group have beaten the market over periods spanning several years.

That's not to say these funds necessarily will maintain their standout performance. In most years, a majority of managed funds fail to beat the market. What's more, a wealth of research has shown that a fund's expenses are almost always a more significant factor in long-term returns than any edge a manager can achieve.

But it's hard to argue with the results the four funds below have delivered, or with the fees charged. Each invests primarily in large U.S. companies, the types of stocks that typically anchor a well-diversified portfolio. Each has outperformed a large-cap stock index, the Russell 1000, over the latest five- and 10-year periods. The funds have accomplished that while charging fees that are below 0.74 percent. That's the average expense ratio that investors paid last year to invest in U.S. stock funds of all types, managed and index, according to Morningstar.

Each of the four requires a minimum initial investment of $3,000 or less, so the funds are accessible to most individual investors. None charges an upfront sales fee, known as a load.

The four, listed in order of their 10-year returns:

MAIRS & POWER GROWTH (MPGFX)

This fund barely made the cut because its expense ratio of 0.71 percent is only slightly below average. But it's a standout in several other respects. Its 10-year return places the fund within the top 10 percent among its large-cap blend peers, which invest in a mix of value- and growth-oriented stocks. It's also in the top 10 percent over the past five-year period and 12 months.

The fund's managers, William Frels and Mark Henneman, typically invest a substantial portion of the portfolio in companies with headquarters in Minnesota or neighboring states. That's the region that the St. Paul-based managers know best. At latest count, the fund held 47 stocks, with Minnesota-based Valspar, 3M, Target, Ecolab and U.S. Bancorp making up the top five holdings. The fund tends to hold stocks for years before trading them. Three of those top five holdings have been in the portfolio since 1993.

VANGUARD DIVIDEND GROWTH (VDIGX)

This is one of the standout managed funds at Vanguard, best known for index funds. With an expense ratio of just 0.31 percent, it's among the lowest-cost managed funds. The emphasis in the portfolio of around 50 stocks is dividend-payers. Recent top holdings include PepsiCo, Johnson & Johnson, Occidental Petroleum, Target and Exxon Mobil.

Morningstar analysts currently give the fund a top-rung gold medal ranking, based on their assessment of its future prospects. Among other things, Morningstar cites the fund's stable management. Don Kilbride has run the fund the past six years, and has more than $1 million personally invested in the fund.

T. ROWE PRICE GROWTH STOCK (PRGFX)

With expenses of 0.70 percent, this fund also just made the cut. The emphasis is on growth stocks, which typically generate revenue and earnings at an above-average rate. Examples include Apple and Google, the fund's recent top two holdings, making up 11 percent and 3.8 percent of the portfolio, respectively. Apple's recent strong performance has been a big contributor to the fund's 17 percent year-to-date return, which ranks in the top 10 percent among peers. Over 10 years, the fund ranks in the top 20 percent.

Morningstar analysts are cautious about the fund, currently maintaining a "Neutral" rating. One reason is the fund's inability to offer much protection in sharp market declines. In 2008, for example, the fund lost 42 percent, worse than nearly two-thirds of its peers.

VANGUARD EQUITY-INCOME (VEIPX)

This fund takes a similar approach to Vanguard Dividend Growth, focusing on dividend-paying stocks while also charging expenses of just 0.31 percent. But this fund is more diversified than the other, with a portfolio of around 150 stocks. The four-person management team also puts a sharper focus on value-oriented stocks, which tend to generate steady earnings and are considered inexpensive based on their price-to-earnings ratios.

That emphasis can hold the fund back when the market rallies. For example, Equity-Income's 17 percent return in 2009 lagged the Standard & Poor's 500 by 9 percentage points, and trailed nearly nine of 10 peers. But last year, the fund beat that index by 8 percentage points, returning nearly 11 percent. In the large-value category, the fund's five- and 10-year average annualized returns rank within the top 10 percent among its peers.

___

Questions? E-mail the AP at investorinsight(at)ap.org

Join the Discussion
Rate Article: Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Research Exchange

Safety Without Sacrifice

Safety Without Sacrifice

Jun 26

Liquid handling ergonomics and performance considerations

Three Tips to Help Manage Customization in Genomics LIMS Implementations

Nov 21 2011

Labs must consider three elements in evaluating genomics laboratory information management system (LIMS) to support the ever-changing workflow characteristics of next-generation sequencing.

How to Build an Integrated Microscopy System for Live Cell Mechanotransduction Studies

How to Build an Integrated Microscopy System for Live Cell Mechanotransduction Studies

Aug 2 2011

A new integrated microscopy system allows scientists to simultaneously stimulate and image live cell response in real-time.

Tips for Reducing Static Electricity

Tips for Reducing Static Electricity

Aug 1 2011

Static electricity can affect automated instrumentation within the lab.

Evaluation of a New Nano-Type UV-Vis Spectrophotometer

Mar 3 2011

Analysis of one- to four-microliter size samples for nucleic acids has become routine in many life science laboratories. However, until now, available instruments require considerable manipulation of the instrument and sample; some require manually recording the data. The user must typically lower and raise the arm manually, then wipe the sample manually from the target after each analysis. And fiberoptics used in some of these instruments are subject to deterioration.

Production of Recombinant Proteins and Monoclonal Antibodies in Hollow Fiber Bioreactors

Jan 25 2011

While well-understood, robust and convenient, classical batch-style 2-D culture on non-porous supports or 3-D suspension culture in other devices are really not very biologically relevant models. Cell culture conditions can affect the quality of the antibody or protein produced.

Selecting Robots for Use in Drug Discovery and Testing

Dec 6 2010

Drug discovery and testing, with their need for speed, repeatability and verification, are ideally suited to benefit from robot automation. It is therefore not surprising that robots have been at the forefront of automation developments in both these areas.

HP Scalable Network Storage Systems for Life Sciences

Sep 13 2010

Life sciences research today is advancing exponentially, each step bringing us closer to the realization of truly personalized medicine–preventive care and treatments designed specifically for each individual. In the near future, PCPGM healthcare researchers expect to be able to use predictive genetic testing to create custom treatment plans for individuals and deliver dramatic improvements over today’s one-size-fits-all approach. But research capabilities are only part of the equation; current storage and operating capacities must also evolve to accommodate ever-expanding amounts of data before the goal of personalized medicine can be realized.

Using the Tecan Genesis Workstation to Automate a Cytometric Bead Array (CBA) Immunoassay

Mar 11 2010

The poster describe the process involved in automating a Cytometric Bead Array (CBA) immunoassay developed to measure relative concentrations of serum antibodies against Tetanus (TT), Sperm Whale Myoglobin (SWM) and Keyhole Limpet Hemocyanin (KLH) in KLH-immunized volunteers.

Ensuring Quality in Assays Performed with Automated Liquid Handlers

Feb 2 2010

The focus of this presentation is to highlight the need of ensuring quality in important assays performed with automated liquid handlers. Nearly all assays performed within a laboratory are volume-dependent. In turn, all concentrations of biological and chemical components in these assays, as well as the associated dilution protocols, are volume-dependent. Because analyte concentration is volume-dependent, an assay’s results might be falsely interpreted if liquid handler variability and inaccuracies are unknown or if the system(s) go unchecked for a long period.

Inkjet System for Protein Crystallography

Feb 1 2010

X-ray crystallography is used routinely by scientists to obtain the three dimensional structure of a biological molecule of interest.Such information can be used to determine how a pharmaceutical interacts with a protein target and what changes might improve functionality. However, the crystallization of macromolecules still remains a serious hindrance in structural determination despite impressive advances in screening methods and technologies.

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Nov 9 2009

Action selection is modulated by external stimuli either directly or via memory retrieval. In a constantly changing environment, animals have evolved attention-like processes to effectively filter the incoming sensory stream. These attention-like processes, in turn, are modulated by memory. The neurobiological nature of how attention, action selection and memory are inter-connected is unknown. We describe here new phenotypes of the memory mutant radish in the fruit fly Drosophila.

Red Meat Consumption and Mortality: Results From 2 Prospective Cohort Studies

Mar 16

BACKGROUND: Red meat consumption has been associated with an increased risk of chronic diseases. However, its relationship with mortality remains uncertain. METHODS: We prospectively observed 37 698 men from the Health Professionals Follow-up Study (1986-2008)...

Structural analysis of eyespots: dynamics of morphogenic signals that govern elemental positions in butterfly wings.

Mar 15

ABSTRACT: BACKGROUND: To explain eyespot colour-pattern determination in butterfly wings, the induction model has been discussed based on colour-pattern analyses of various butterfly eyespots. However, a detailed structural analysis of eyespots that can serve as...

Prokariotic Cell Collection in Denmark

Nov 6 2009

I would like to know about a prokariotic cell collection in Denmark. Is there a cell bank in this country? I need a Lactobacillus strain for a fermentation assay and this information about the bank is very helpful for me.

Request for Entries

Oct 16 2009

Ask the Experts is your chance to get the answers to questions on applications, materials, methods, processes, and technologies. Email you question to bst_web@advantagemedia.com, and the editors of Bioscience Technology will find an appropriate expert to answer it. Watch this space in the future to see the questions your colleagues are posting.

STAY INFORMED: SUBSCRIBE TO

Magazine and E-mail Newsletters

Loading...
Loading...

Free Life Science Industry
Subscriptions

Magazine

wireless week

Newsletters

newsletters

Sign up now



MULTIMEDIA

Video:

Viewing SureFocus Slides

Jun 11 2010

A demonstration of SureFocus Microscope Slides in the review of AFB Smears. SureFocus Slides are a patent-pending breakthrough in tuberculosis detection, as their fluorescent staining circle remains visible during review, Fluorescence Microscopy.

Podcasts:

Futures In Biotech 93: Snyder's Omics

May 17

Host: Marc Pelletier Co-Host: Andre Nantel, Ph.D. The technologies that our guest has developed are playing an important role in changing the world, not like the car, the microwave and the cell phone, but as in Drs. Flox, McCoy, and Crusher. Guest: Dr. Michael Snyder We invite...

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter

Information: